Why the study?
Does captopril reduce arterial pressure and alter the renin-angiotensin-aldosterone system in patients with renovascular or intractable hypertension?
Population
15 patients
Design
Case_series
Follow-up
up to 6 weeks (and prolonged treatment)
Authors
Loading...
May support captopril in renovascular hypertension; leaves open confirmation in randomized trials.
Does captopril reduce arterial pressure and alter the renin-angiotensin-aldosterone system in patients with renovascular or intractable hypertension?
Captopril effectively lowers blood pressure and modulates the renin-angiotensin-aldosterone system in patients with renovascular or previously intractable hypertension.
Atkinson et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: